Imperial College LondonLondon, Englanddisease: HIVSt. George's University of LondonLondon, UKdisease: HIVUK Consortium on AIDS and International DevelopmentLondon, UKdisease: HIVUK HIV Vaccine ConsortiumLondon, UKdisease: HIV
Institute of Endemic DiseasesKhartoum, Sudandisease: Leishmaniasis
Institute of Human VirologyBaltimore, MDdisease: HIV
Instituto ButantanSao Paulo, Brazildisease: Leishmaniasis
Institute de BiomedicinaCaracas, Venezueladisease: Leishmaniasis
Institute de lnfectologia Emilio RibasSao Paulo, Brazildisease: Leprosy
IOWA State UniversityAmes, IAdisease: LeishmaniasisUniversity of IowaIowa City, IAdisease: Leishmaniasis
Cebu Leprosy and Tuberculosis Research FoundationCebu, Philippinesdisease: TB, Leprosy
Laboratory of Malaria Vector Research/NIHBethesda, MDdisease: MalariaWalter Reed Army Institute of ResearchSilver Spring, MDdisease: Malaria
LSU Veterinary School of MedicineBaton Rouge, LAdisease: Leprosy, TB
Massachusetts Institute of TechnologyCambridge, MAdisease: Malaria
MCRF/Institute of Microbial ChemistryTokyo, Japandisease: TB
Medicago ResearchQuebec, Canadadisease: Flu
MerialDuluth, GAdisease: Leishmaniasis
NanoPassNes Ziona, Israeldisease: Various
National Institute of Infectious DiseasesTokyo, Japandisease: Leprosy
Orange LifeRio de Janeiro, Brazildisease: Leishmaniasis, TB, LeprosyOswaldo Cruz Foundation-FIOCRUZRio de Janeiro, Brazildisease: Leishmaniasis, TB, Leprosy
PECET Universidad de AntioquiaMedellin, Columbiadisease: Leprosy
Research Triangle InternationalResearch Triangle Park, NCdisease: TB
Addis Ababa University: The first step to successfully treating a disease is accurate diagnosis. IDRI is working with collaborators at Addis Ababa University to develop the next generation diagnostic to diagnose forms of leishmaniasis that are specific to that region in Africa.
INDIA: Where is the best place to produce vaccines to prevent infectious diseases? At IDRI, we believe it’s in the countries where they are needed most. To produce products that will be used to combat deadly diseases in India, IDRI partnered with Gennova Pharmaceuticals to build a facility and transfer IDRI technology to produce antigen and/or adjuvant formulations for vaccines to combat malaria, tuberculosis and leishmaniasis.
Orange LifeRio de Janeiro, Brazildisease: Leishmaniasis, TB, Leprosy
OrangeLife: In Brazil, the bite of a tiny sand fly can change a life – causing a debilitating disease called leishmaniasis. Our partners in Brazil, OrangeLife, used IDRI technology to develop a rapid diagnostic test for leishmaniasis, as well as leprosy, another disease prevalent in Brazil. Early detection and effective vaccines – also being developed by IDRI scientists – can bring these diseases under control.
South African Tuberculosis Vaccine InitiativeCape Town, South Africadisease: Tuberculosis
Deadly co-infections of HIV/AIDS and TB are problematic around the world, but particularly in Africa. Key to stopping TB is developing a vaccine. IDRI is partnering with the South African Tuberculosis Vaccine Initiative, part of the University of Cape Town, to move toward this goal by conducting additional clinical trials there.